Jeffrey P. Gregg, M.D.
Associate Professor, Department of Pathology, School of Medicine; Director, Molecular Pathology Shared Resource, UC Davis Cancer Center, and MIND Institute Genomics Facility
UC Davis MIND Institute
2825 50th Street
Sacramento, CA 95817
During the last several years, Dr. Gregg, an expert in microarray technology, has moved into the neurosciences and research on autism. In the autism arena, Dr. Gregg has taken a unique approach to studying autism in which he uses microarray technology to perform gene expression studies of the entire genome of peripheral lymphocytes in order to identify genes associated with autism. This approach, called “blood genomics” has great potential but is still in its infancy. In the recent year, Dr. Gregg has had several exciting publications on this subject. These data suggest that blood genomics may be able to identify biomarkers for diagnosis and classification of autism. In addition to these microarray studies, he is adapting microarray technology to identify gains and losses (i.e., duplications and deletions) in the genome of children with autism.
B.A., Biology, University of California, San Diego, 1989
M.D., Medicine, University of California, Los Angeles, 1993